


Ask a doctor about a prescription for REMINYL 4 mg/ml ORAL SOLUTION
Package Leaflet: Information for the User
Galantamine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Reminyl contains the active substance “galantamine”, an anti-dementia medicine. It is used in adults to treat the symptoms of mild to moderately severe Alzheimer's disease, a type of dementia that affects memory and thinking.
Alzheimer's disease causes increasing memory loss, confusion, and changes in behavior, making it difficult to perform daily activities.
These effects are thought to be caused by a lack of “acetylcholine”, a substance responsible for transmitting messages between brain cells. Reminyl increases the amount of acetylcholine in the brain and in this way treats the symptoms of the disease.
Do not take Reminyl
Warnings and precautions
Talk to your doctor or pharmacist before you start taking Reminyl. This medicine should only be used in Alzheimer's disease and is not recommended for other types of memory loss or confusion.
Severe side effects
Reminyl may cause severe skin reactions, heart problems, and seizures. You should be aware of these side effects while taking Reminyl. See section 4 “Be aware of severe side effects”.
Before starting treatment with Reminyl, your doctor should know if you have or have had any of the following conditions:
Your doctor will decide if Reminyl is suitable for you or if the dose needs to be changed.
Tell your doctor if you have recently had an operationon your stomach, intestine, or bladder. Your doctor will decide if Reminyl is suitable for you.
Reminyl may cause weight loss.Your doctor will check your weight regularly while you are taking Reminyl.
Children and adolescents
Reminyl is not recommended for use in children or adolescents.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Reminyl should not be taken with medicines that work in the same way. These include:
Some medicines may increase the risk of side effects in people taking Reminyl. These include:
If you are taking any of these medicines, your doctor may give you a lower dose of Reminyl.
Reminyl may affect some anesthetics. If you are going to have a general anesthetic, tell your doctor well in advance that you are taking Reminyl.
Talk to your doctor or pharmacist if you have any questions.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not breastfeed while taking Reminyl.
Reminyl may make you feel dizzy or sleepy, especially during the first few weeks of treatment. If Reminyl affects you, do not drive or use machines.
Reminyl Oral Solution contains methyl parahydroxybenzoate and propyl parahydroxybenzoate.
These may rarely cause allergic reactions (which may be delayed).
Reminyl Oral Solution contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per 6 ml of Reminyl 4 mg/ml oral solution (equivalent to the maximum daily dose of Reminyl); this is essentially “sodium-free”.
Follow the instructions for administration of this medicine exactly as told by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist again.
How much to take
You will start treatment with Reminyl at a low dose. The usual starting dose is 4 mg (1 mL of solution), taken twice a day (a total of 8 mg per day). Your doctor will gradually increase your dose, every 4 weeks or more, until you reach the dose that is best for you. The maximum dose is 12 mg (3 mL of solution), taken twice a day (a total of 24 mg per day).
Your doctor will tell you which dose to start with and when to increase it. If you are unsure what to do or find that the effect of Reminyl is too strong or too weak, talk to your doctor or pharmacist.
Your doctor needs to see you regularly to check that this medicine is working and to talk to you about how you are feeling.
If you have liver or kidney problems,your doctor may give you a lower dose of Reminyl or may decide that this medicine is not suitable for you.
How to take it
Take your dose of Reminyl twice a day, in the morning and evening, with water or other liquids. Try to take Reminyl with food.
Drink plenty of liquid while taking Reminyl to stay hydrated.
The solution comes with a syringe, which can be used to draw up the exact amount needed from the bottle.
Instructions for opening the bottle and using the syringe
Fig. 1: The bottle has a child-resistant cap and should be opened as follows:
Fig. 2: Insert the syringe into the bottle. While holding the lower ring, pull the upper ring up to the mark corresponding to the number of milliliters you want to administer. Fig. 3: Hold the lower ring and remove the syringe completely from the bottle. Empty the syringe into any non-alcoholic drink by sliding the upper ring down and drink immediately. Close the bottle. Rinse the syringe with water. |
|
If you take more Reminyl than you should
In case of overdose or accidental ingestion, talk to your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. Bring any remaining solution with you. Signs of an overdose may include:
If you forget to take Reminyl
If you forget to take a dose, skip that dose and continue with your treatment as usual with the next scheduled dose. Do not take a double dose to make up for forgotten doses.
If you forget to take more than one dose, talk to your doctor.
If you stop taking Reminyl
Talk to your doctor before stopping treatment with Reminyl. It is important to continue taking this medicine to treat your condition.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Be aware of severe side effects
Stop taking Reminyl and talk to a doctor or go to the nearest emergency room immediatelyif you notice any of the following side effects:
Skin reactions,including:
These skin reactions are rare in people taking Reminyl (may affect up to 1 in 1,000 people).
Heart problemsincluding changes in heartbeat (such as slow or extra beats) or palpitations (feeling your heartbeat is fast or irregular). Heart problems can be seen as an abnormal tracing on an “electrocardiogram” (ECG), and may be common in people taking Reminyl (may affect up to 1 in 10 people).
Seizures. This is uncommon in people taking Reminyl (may affect up to 1 in 100 people).
You must stop taking Reminyl and seek help immediatelyif you notice any of the side effects mentioned.
Other side effects
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency's Pharmacovigilance System for Human Use: https://www.notificaram.es/. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date is the last day of the month shown.
Do not freeze.
Reminyl Oral Solution should not be used for more than 3 months after the bottle is first opened.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for proper disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Reminyl
Methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), purified water, sodium saccharin, and sodium hydroxide.
Appearance and Packaging of the Product
Reminyl is a clear, colorless oral solution available in a 100 mL bottle.
The solution comes with a syringe, which can be used to draw up the exact amount needed from the bottle.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Essential Pharma Limited,
Vision Exchange Building,
Triq it-Territorjals, Zone 1,
Central Business District,
Birkirkara, CBD 1070,
Malta
Manufacturer
Janssen-Pharmaceutica, N.V.
Turnhoutseweg, 30
B-2340 Beerse
Belgium
This medicine is authorized in the Member States of the European Union under the following names:
Austria Reminyl 4 mg/ml Oral Solution
Belgium Reminyl 4 mg/ml, oral solution
Denmark Reminyl 4 mg/ml oral solution
Finland Reminyl 4 mg/ml oral solution
France Reminyl 4 mg/ml, oral solution
Greece Reminyl 4 mg/ml ?????? ?????
Ireland Reminyl 4 mg/ml oral solution
Italy Reminyl 4 mg/ml oral solution
Norway Reminyl 4 mg/ml oral solution
Portugal Reminyl 4 mg/ml oral solution
Spain Reminyl 4 mg/ml oral solution
Sweden Reminyl 4 mg/ml oral solution
United Kingdom (Northern Ireland) Reminyl 4 mg/ml oral solution
This leaflet was approved in:October 2021.
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for REMINYL 4 mg/ml ORAL SOLUTION – subject to medical assessment and local rules.